Short Interest in Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Decreases By 35.4%

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) was the target of a significant decline in short interest in August. As of August 14th, there was short interest totaling 11,255 shares, a decline of 35.4% from the July 30th total of 17,416 shares. Based on an average trading volume of 30,001 shares, the days-to-cover ratio is presently 0.4 days. Currently, 1.2% of the company’s stock are sold short.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded Cuprina Holdings (Cayman) from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 26th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Cuprina Holdings (Cayman) has a consensus rating of “Sell”.

Cuprina Holdings (Cayman) Stock Down 0.3%

NASDAQ CUPR traded down $0.01 during trading hours on Tuesday, reaching $2.90. 4,794 shares of the company traded hands, compared to its average volume of 1,269,069. The company has a current ratio of 2.35, a quick ratio of 2.35 and a debt-to-equity ratio of 0.07. Cuprina Holdings has a 12 month low of $1.76 and a 12 month high of $19.60. The company has a 50 day moving average of $3.87 and a two-hundred day moving average of $3.24.

Cuprina Holdings (Cayman) Company Profile

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.